Catalyst Pharmaceuticals Inc (CPRX)
21.81
-0.08
(-0.37%)
USD |
NASDAQ |
Nov 04, 13:02
Catalyst Pharmaceuticals 1 Year Total Returns (Daily): 73.18% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 73.18% |
October 31, 2024 | 75.66% |
October 30, 2024 | 76.72% |
October 29, 2024 | 81.34% |
October 28, 2024 | 82.09% |
October 25, 2024 | 65.71% |
October 24, 2024 | 67.79% |
October 23, 2024 | 70.31% |
October 22, 2024 | 67.66% |
October 21, 2024 | 64.22% |
October 18, 2024 | 59.70% |
October 17, 2024 | 54.79% |
October 16, 2024 | 63.55% |
October 15, 2024 | 65.73% |
October 14, 2024 | 61.50% |
October 11, 2024 | 55.15% |
October 10, 2024 | 54.22% |
October 09, 2024 | 56.26% |
October 08, 2024 | 60.26% |
October 07, 2024 | 57.46% |
October 04, 2024 | 65.43% |
October 03, 2024 | 66.92% |
October 02, 2024 | 69.78% |
October 01, 2024 | 72.97% |
September 30, 2024 | 70.06% |
Date | Value |
---|---|
September 27, 2024 | 60.72% |
September 26, 2024 | 64.33% |
September 25, 2024 | 64.88% |
September 24, 2024 | 69.42% |
September 23, 2024 | 69.34% |
September 20, 2024 | 70.69% |
September 19, 2024 | 67.98% |
September 18, 2024 | 61.89% |
September 17, 2024 | 64.04% |
September 16, 2024 | 64.04% |
September 13, 2024 | 58.84% |
September 12, 2024 | 56.92% |
September 11, 2024 | 52.27% |
September 10, 2024 | 52.04% |
September 09, 2024 | 54.24% |
September 06, 2024 | 51.94% |
September 05, 2024 | 53.17% |
September 04, 2024 | 43.03% |
September 03, 2024 | 41.81% |
August 30, 2024 | 40.24% |
August 29, 2024 | 41.60% |
August 28, 2024 | 43.42% |
August 27, 2024 | 43.75% |
August 26, 2024 | 44.31% |
August 23, 2024 | 43.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-56.93%
Minimum
Sep 11 2020
265.6%
Maximum
Jan 20 2023
44.78%
Average
33.90%
Median
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | 61.12% |
Vertex Pharmaceuticals Inc | 27.56% |
Regenxbio Inc | -38.06% |
Edgewise Therapeutics Inc | 427.1% |
Entrada Therapeutics Inc | 13.55% |